<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test identifies high-risk subjects for <z:mp ids='MP_0002055'>diabetes</z:mp>, but it is costly and inconvenient </plain></SENT>
<SENT sid="1" pm="."><plain>To find better predictors of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, we evaluated two different definitions of the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> because <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, which is commonly associated with this clustering of metabolic factors, frequently precedes the <z:hpo ids='HP_0003674'>onset</z:hpo> of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We compared the ability of the National Cholesterol Education Program (NCEP) definition, a modified version of the 1999 World Health Organization (WHO) definition that excludes the 2-h <z:chebi fb="105" ids="17234">glucose</z:chebi> requirement, and <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) to predict incident type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In the San Antonio Heart Study, 1734 participants completed a 7- to 8-year follow-up examination </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: IGT and the NCEP definition had higher sensitivity than the modified WHO definition (51.9, 52.8, and 42.8%, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>IGT had a higher positive predictive value than the NCEP and modified WHO definitions (43.0, 30.8, and 30.4%, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>The combination of the IGT and NCEP definitions increased the sensitivity to 70.8% with an acceptable positive predictive value of 29.7% </plain></SENT>
<SENT sid="7" pm="."><plain>Risk for incidence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> using the NCEP definition was independent of other risk factors, including IGT and fasting insulin (odds ratio 3.30, 95% CI 2.27-4.80) </plain></SENT>
<SENT sid="8" pm="."><plain>The NCEP definition performed better with fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> &gt;or=5.4 mmol/l (sensitivity 62.0% and positive predictive value 30.9%) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> predicts <z:mp ids='MP_0002055'>diabetes</z:mp> independently of other factors </plain></SENT>
<SENT sid="10" pm="."><plain>However, the NCEP definition performs better than the modified 1999 WHO definition </plain></SENT>
<SENT sid="11" pm="."><plain>Lowering the fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> cutoff to 5.4 mmol/l improves the prediction of <z:mp ids='MP_0002055'>diabetes</z:mp> by the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
</text></document>